Clinical Trial Update: Post-marketing Surveillance of Donepezil Hydrochloride - Investigation of Long Term Safety and Efficacy of Aricept as Well as Its Proper Use Information in Patients With Dementia With Lewy Bodies (DLB).

View source ↗

Summary

This post-marketing surveillance study evaluates the long-term safety and efficacy of Aricept (donepezil hydrochloride) in patients with dementia with Lewy bodi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dementia with Lewy Bodies

Drugs mentioned

• Aricept (Donepezil)

Snippet

Sponsor: Eisai Co., Ltd. | Conditions: Dementia With Lewy Body Disease | Status: COMPLETED